| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/12/2002 | WO2002069793A2 Extracorporeal blood processing information management system |
| 09/12/2002 | WO2002014369A3 Human kininogen d5 domain polypeptides and their use |
| 09/12/2002 | WO2001093914A3 Multivalent platform molecules comprising high molecular weight polyethylene oxide |
| 09/12/2002 | WO2001089558A3 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states |
| 09/12/2002 | WO2001045641A3 Inhibitors of thrombin induced platelet aggregation |
| 09/12/2002 | WO2001041794A3 Activated amylase |
| 09/12/2002 | WO2001013933A9 Agents for the enhanced oxygen delivery in mammals |
| 09/12/2002 | US20020128471 Useful for treating cellular hyperproliferation |
| 09/12/2002 | US20020128306 Programmed cell death; expansion of hematopoietic cells, for prolonging viability of an organ for transplantation, and maintaining viability of cell lines used in bioproduction |
| 09/12/2002 | US20020128259 Using a vasopressin antagonist such as conivaptan |
| 09/12/2002 | US20020128240 Treatment of hyperproliferative diseases using active vitamin D analogues |
| 09/12/2002 | US20020128225 Methods and products related to pulmonary delivery of polysaccharides |
| 09/12/2002 | US20020128207 Dried blood factor composition comprising trehalose |
| 09/12/2002 | US20020128183 Gene regulation therapy involving ferritin |
| 09/12/2002 | US20020128182 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 09/12/2002 | US20020127694 2786, a novel human aminopeptidase |
| 09/12/2002 | US20020127647 ATP-binding cassette transporter-like molecules and uses thereof |
| 09/12/2002 | US20020127235 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/12/2002 | US20020127222 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 09/12/2002 | US20020127213 Administering to patient a therapeutically effective amount of both an N-alkyl derivative of deoxynojirimycin and a glucocerebrosidase enzyme to alleviate or inhibit glycolipid storage disease; Gaucher's disease |
| 09/12/2002 | DE10110750A1 Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel Aminodicarbonsäurederivate with pharmaceutical properties |
| 09/12/2002 | DE10110749A1 Substituierte Aminodicarbonsäurederivate Substituted Aminodicarbonsäurederivate |
| 09/12/2002 | DE10109855A1 Polypeptide eines p53-Protein-spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptide of a p53 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | CA2445004A1 Polypeptides of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2440642A1 Dimeric isoflavones |
| 09/12/2002 | CA2440092A1 Protein c variants |
| 09/12/2002 | CA2439941A1 Secreted proteins |
| 09/12/2002 | CA2439939A1 Novel aminodicarboxylic acid derivatives |
| 09/12/2002 | CA2439926A1 Modified human granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 09/12/2002 | CA2439759A1 Substituted amino dicarboxylic acid derivatives |
| 09/12/2002 | CA2439687A1 Use of certain steroids for treatment of blood cell deficiencies |
| 09/12/2002 | CA2439647A1 Side-chain-halogenated aminodicarboxylic acid derivatives as medicaments for treatment of cardiovascular disorders |
| 09/12/2002 | CA2439644A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 09/12/2002 | CA2439594A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | CA2439489A1 Preparation of warfarin sodium from warfarin sodium-2-propanol clathrate by solvent expulsion |
| 09/12/2002 | CA2439205A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439203A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439200A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439197A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439196A1 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | CA2439195A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439192A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2438737A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists |
| 09/12/2002 | CA2438623A1 Extracorporeal blood processing information management system |
| 09/12/2002 | CA2437594A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | CA2433933A1 Use of lp82 to treat hematopoietic disorders |
| 09/12/2002 | CA2431549A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 09/11/2002 | EP1238675A1 Recombinant gelatin-like proteins for use as plasma expanders |
| 09/11/2002 | EP1238667A2 Use of benzothiophenes for treatment of hypercholesterolaemia |
| 09/11/2002 | EP1238070A2 Therapeutically useful synthetic oligonucleotides |
| 09/11/2002 | EP1238016A1 Substituted phthalocyanines and their precursors |
| 09/11/2002 | EP1237936A1 Molecularly inprinted polymers produced by template polymerisation |
| 09/11/2002 | EP1237917A2 Protein c derivatives |
| 09/11/2002 | EP1237902A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 09/11/2002 | EP1237897A2 Antithrombotic compound |
| 09/11/2002 | EP1237891A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 09/11/2002 | EP1237888A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/11/2002 | EP1237864A1 Process for the preparation of amorphous atorvastatin |
| 09/11/2002 | EP1237849A1 Activators of soluble guanylate cyclase |
| 09/11/2002 | EP1237582A2 Methods for introducing genes into mammalian subjects |
| 09/11/2002 | EP1237575A1 Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
| 09/11/2002 | EP1237565A1 Betaglycan as an inhibin receptor and uses thereof |
| 09/11/2002 | EP1237559A1 Pharmaceutical combinations |
| 09/11/2002 | EP1237548A1 Il-8 receptor antagonists |
| 09/11/2002 | EP1237537A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 09/11/2002 | EP1165122B1 Use of molecular weight-amplified hirudin as an anticoagulant in extracorporeal renal replacement therapy |
| 09/11/2002 | EP1054892B1 Azole peptidomimetics as thrombin receptor antagonists |
| 09/11/2002 | EP0989854A4 Compositions useful as fibrin sealants |
| 09/11/2002 | EP0958287B1 Sulfamide-metalloprotease inhibitors |
| 09/11/2002 | EP0880363B1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 09/11/2002 | EP0763036B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 09/11/2002 | CN1369015A Recombinant anti-CD 40 antibody and uses thereof |
| 09/11/2002 | CN1368970A Substituted 1,4-dihydroindeno [1,2-C] pyrazoles as inhibitors of tyrosine kinase |
| 09/11/2002 | CN1368962A Fluorene derivatives |
| 09/11/2002 | CN1368960A Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 09/11/2002 | CN1368957A Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha |
| 09/11/2002 | CN1368948A Crystals of sodium salt of pravastatin |
| 09/11/2002 | CN1368853A Prophylactic dietary supplement based on milk |
| 09/11/2002 | CN1368381A Liquid T cell factor preparation |
| 09/11/2002 | CN1368351A Nano medicine 'Hexue' and its preparing process |
| 09/11/2002 | CN1368334A Nano emdicine 'Weiling' and its preparing process |
| 09/11/2002 | CN1368331A Nano medicine 'Yaomu' and its preparing process |
| 09/11/2002 | CN1368290A Nano medicine 'Xiaoer Shengxue' and its preparing process |
| 09/11/2002 | CN1368246A Nano medicine 'Fukang' and its preparing process |
| 09/11/2002 | CN1368240A Nano emdicine 'Buxue Tiaojing' and its preparing process |
| 09/11/2002 | CN1368223A Nano medicine 'Danggui Yixue' and its preparing process |
| 09/11/2002 | CN1368221A Nano medicine 'Tiaojingzhitong' and its preparing process |
| 09/11/2002 | CN1368201A Nano medicine 'Fukangbao' and its preparing process |
| 09/11/2002 | CN1368196A Nano medicine 'Aguiyangxue' and its preparing process |
| 09/11/2002 | CN1368195A Nano medicine 'Buxuedanggui' and its preparing process |
| 09/11/2002 | CN1368160A Nano medicine 'Jianpibuxue' and its preparing process |
| 09/11/2002 | CN1368152A Nano medicine 'Guilong' and its preparing process |
| 09/11/2002 | CN1368128A Nano medicine 'Lujiaobuxue' and its preparing process |
| 09/11/2002 | CN1368113A Nano Medicine 'Xuezaisheng' and its preparing process |
| 09/11/2002 | CN1368095A Nano medicine 'Lutai' and its preparing process |
| 09/11/2002 | CN1368083A Nano medicine 'Pianzaihuang' and its preparing process |
| 09/11/2002 | CN1368061A Nano meidcine 'Xiaoshuan Tongluo' and its preparing process |
| 09/11/2002 | CN1090676C Expression systems utilizing autolyzing fusion proteins and novel reducing polypeptide |
| 09/11/2002 | CN1090508C Storage stable water solution for infusion containing thrombin inhibitor |
| 09/11/2002 | CN1090494C Medicine for treating aplastic anemia acute granulocytic leukemia and chronic granulocytic leukemia |